why choose us

First received: June 30, 2023

Clinical Trial: A Study of LY3502970 in Participants With Normal and Impaired Renal Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Renal Insufficiency

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Parallel, Single-Dose, Open-Label, Single-Period Study of LY3502970 in Participants With Normal Renal Function and Participants With Renal Impairment

Brief Summary: The main purpose of this study is to assess the amount of study drug (LY3502970) that reaches the bloodstream and the time it takes for the body to get rid of it when given to participants with renal (kidney) impairment compared to participants with normal renal function.The safety and tolerability of LY3502970 will also be evaluated in these participants.The study will last up to 6 weeks including screening period.

Read more